Q1 2026 cbdMD Inc Earnings Call Transcript

Feb 17, 2026 / 09:20 PM GMT

Release Date Price: $0.7764 (+10.72%)

Transcript 10-Q

Key Points

Positve

cbdMD Inc (YCBD) regained compliance with NYC listing requirements, improving its market standing.
The company completed a $2.25 million Series C preferred financing, enhancing liquidity and working capital.
A $20 million equity line of credit was structured, providing financial flexibility under favorable market conditions.
Net loss per share improved significantly from $1.73 to $0.04, reflecting better financial management.
The acquisition of Bluebird Botanicals is expected to unlock synergies and expand the customer base.

Negative

Net sales slightly decreased from $5.1 million to $5 million compared to the prior year period.
Gross margin declined from 66% to 60%, primarily due to increased warehouse expenses and a shift to more wholesale revenue.
Loss from operations increased to $286,000 from $86,000 in the prior year period.
The regulatory environment remains uncertain, with potential industry-wide impacts from restrictive hemp legislation.
The Herbal Oasis line of seltzers is still a small contributor to overall sales, indicating slower-than-expected growth in this segment.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

YCBD.A - cbdMD Inc
Q1 2026 cbdMD Inc Earnings Call
Feb 17, 2026 / 09:20PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Accretive, defensible, and aligned with our regulatory strategy.

Another key area of progress this quarter was our balance sheet.

As a result of the efforts throughout fiscal 2025, we received notice from the NYC in early December confirming we had regained compliance with continued listing requirements that our temporary status had been removed. In December, we completed an approximate 2.25 million in Serious C preferred financing, strengthening our liquidity and working capital.

As of December 31, 2025, we ended the quarter with approximately $3.4 million in cash and 5.4 million in working capital, both meaningfully higher than at fiscal end.

In addition to the Serious C financing, we structured a $20 million equity

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.